Dexrazoxane
Back to searchMolecule Structure
Scientific Name
Dexrazoxane
Description of the Drug
Dexrazoxane is a cytoprotective drug used to prevent and improve cardiomyopathy associated with doxorubicin treatment for metastatic breast cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00380
http://www.drugbank.ca/drugs/DB00380
Brand Name(s)
Cardioxane, Zinecard
Company Owner(s)
Gland Pharma Ltd, Eugia Pharma Specialities Ltd, Hikma Pharmaceuticals Usa Inc, Clinigen Inc, Pfizer Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Iron | METAL | SEQUESTERING AGENT | CHEMBL2363058 |
DNA topoisomerase II | PROTEIN FAMILY | INHIBITOR | CHEMBL2094255 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL18400 | |||
PharmGKB | PA449259 | |||
Human Metabolome Database | HMDB0014524 | |||
DrugBank | DB00380 | |||
PubChem: Thomson Pharma | 14774896 | 14872576 | ||
PubChem | 71384 | |||
LINCS | LSM-5248 | |||
Nikkaji | J22.227E | |||
EPA CompTox Dashboard | DTXSID3040647 | |||
DrugCentral | 839 | |||
Brenda | 156066 | 139374 | 17799 | 227946 |
ChemicalBook | CB2251448 | |||
Guide to Pharmacology | 7330 | |||
rxnorm | ZINECARD | TOTECT | DEXRAZOXANE | DEXRAZOXANE HYDROCHLORIDE |
ChEBI | 50223 | |||
ZINC | ZINC000087515509 |